Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-01-02 @ 5:07 PM
Study NCT ID:
NCT02112357
Status:
UNKNOWN
Last Update Posted:
2014-04-17
First Post:
2014-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility of a Molecular Characterisation Approach to Treatment
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Study Overview
Official Title:
FOrMAT - Feasibility of a Molecular Characterisation Approach to Treatment
Status:
UNKNOWN
Status Verified Date:
2014-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FOrMAT
Brief Summary:
This study will assess the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics. Targeted next generation sequencing of a panel of genes will be performed on tumour specimens and results will be discussed at a Sequencing Tumour Board to establish if a patient is potentially suitable for a targeted therapy.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: